|
To,
Mr. Sunil Jajoo
VP & Cluster Head, Dermatology
Sun Pharmaceutical Industries Ltd.
Dear Mr. Sunil Jajoo,
Subject: Drug utilization pattern in alopecia
In response to your letter dated _________, I agree to participate in the drug utilization study as outlined
by you. I understand that:
- You will provide me with a copy of the study plan, ___ data collection form (DCF)
-
The patients’ identity will not be disclosed in the DCF
My personal details are given below for accuracy of your records.
|